Proteinuria and endothelial dysfunction in stable HIV-infected patients: A pilot study [2]

Journal of Acquired Immune Deficiency Syndromes

Volumn 45, Issue 5, 2007, Pages 596-598

  Gupta, Samir K ^a   Mather, Kieren J ^a   Agarwal, Rajiv ^a   Saha, Chandan K ^a   Considine, Robert V ^a   Dubé, Michael P ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LOPINAVIR PLUS RITONAVIR; PROTEINASE INHIBITOR;

ALBUMINURIA; BLOOD FLOWMETRY; COMORBIDITY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; LETTER; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEINURIA; SCREENING;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; NITROGLYCERIN; PILOT PROJECTS; PROTEINURIA; PYRIMIDINONES; REGIONAL BLOOD FLOW; RITONAVIR; VASODILATION;

EID: 34548070982     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318061d2fa     Document Type: Letter

References (13)

1. Kannel WB, Stampfer MJ, Castelli WP, et al. The prognostic significance of proteinuria: the Framingham study. Am Heart J. 1984;5:1347-1352.
2. Ross MJ, Klotman PE. HIV-associated nephropathy. AIDS. 2004;8:1089-1099.
3. Gupta SK, Parker RA, Robbins GK, et al. The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial. Nephrol Dial Transplant. 2005;10:2237-2242.
4. Stehouwer CD, Fischer HR, van Kuijk AW, et al. Endothelial dysfunction precedes development ofmicroalbuminuria in IDDM. Diabetes. 1995;5:561-564.
5. Solages A, Vita JA, Thornton DJ, et al. Endothelial function in HIV-infected persons. Clin Infect Dis. 2006;9:1325-1332.
6. Stein JH, Klein MA, Bellehumeur JL, et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 2001;3:257-262.
7. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;2:257-265.
8. Shankar SS, Dube MP, Gorski JC, et al. Indinavir impairs endothelial function in healthy HIV-negative men. Am Heart J. 2005;150:933e1-933e7.
9. Grubb JR, Dejam A, Voell J, et al. Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects. J Infect Dis. 2006;11:1516-1519.
10. Dogra GK, Herrmann S, Irish AB, et al. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome. Nephrol Dial Transplant. 2002;12:2220-2225.
11. Stehouwer CD, Henry RM, Dekker JM, et al. Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between micro-albuminuria and endothelial dysfunction - the Hoorn Study. Kidney Int Suppl. 2004;92:S42-S44.
12. Mauss S, Berger F, Schmutz G. Antiretroviral therapy with tenofovir is associated with mild renal dysfunction. AIDS. 2005;1:93-95.
13. Jung O, Bickel M, Ditting T, et al. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant. 2004;9:2250-2258.